160 related articles for article (PubMed ID: 34184638)
1. Glucokinase activating mutation causing hypoglycaemia diagnosed late in adult who fasts for Ramadhan.
Loh WJ; Dacay LM; Tan CSH; Ang SF; Yap F; Lim SC; Khoo J
Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34184638
[TBL] [Abstract][Full Text] [Related]
2. Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.
Challis BG; Harris J; Sleigh A; Isaac I; Orme SM; Seevaratnam N; Dhatariya K; Simpson HL; Semple RK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):855-61. PubMed ID: 24890200
[TBL] [Abstract][Full Text] [Related]
3. Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.
Christesen HB; Brusgaard K; Beck Nielsen H; Brock Jacobsen B
Clin Endocrinol (Oxf); 2008 May; 68(5):747-55. PubMed ID: 18208578
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
Wabitsch M; Lahr G; Van de Bunt M; Marchant C; Lindner M; von Puttkamer J; Fenneberg A; Debatin KM; Klein R; Ellard S; Clark A; Gloyn AL
Diabet Med; 2007 Dec; 24(12):1393-9. PubMed ID: 17976205
[TBL] [Abstract][Full Text] [Related]
5. An evolving spectrum of diabetes in a woman with GCK-MODY.
Garrahy A; Mijares Zamuner MB; Byrne MM
Endocrinol Diabetes Metab Case Rep; 2019 Jan; 2019():. PubMed ID: 30608898
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations.
Li C; Juliana CA; Yuan Y; Li M; Lu M; Chen P; Boodhansingh KE; Doliba NM; Bhatti TR; Adzick NS; Stanley CA; De León DD
Diabetes; 2023 Dec; 72(12):1809-1819. PubMed ID: 37725835
[TBL] [Abstract][Full Text] [Related]
7. TWO OPPOSITE PHENOTYPES OF GLUCOSE DISORDERS IN A FAMILY WITH HETEROZYGOUS P.SER453LEU (C.1358C> T) MUTATION IN THE GLUCOKINASE (GCK) GENE: MATURITY ONSET DIABETES IN YOUNG AND INSULINOMA.
Demiral M; Çelebi HBG; Cander S; Yerci O; Eren E; Demirbilek H
Acta Endocrinol (Buchar); 2022; 18(4):458-465. PubMed ID: 37152879
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in phenotype of hyperinsulinism caused by activating glucokinase mutations: a novel mutation and its functional characterization.
Martínez R; Gutierrez-Nogués Á; Fernández-Ramos C; Velayos T; Vela A; ; Navas MÁ; Castaño L
Clin Endocrinol (Oxf); 2017 Jun; 86(6):778-783. PubMed ID: 28247534
[TBL] [Abstract][Full Text] [Related]
9. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
10. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
[TBL] [Abstract][Full Text] [Related]
11. Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and management.
Challis BG; Powlson AS; Casey RT; Pearson C; Lam BY; Ma M; Pitfield D; Yeo GSH; Godfrey E; Cheow HK; Chatterjee VK; Carroll NR; Shaw A; Buscombe JR; Simpson HL
Endocr Connect; 2017 Oct; 6(7):540-548. PubMed ID: 28784625
[TBL] [Abstract][Full Text] [Related]
12. Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene.
Barbetti F; Cobo-Vuilleumier N; Dionisi-Vici C; Toni S; Ciampalini P; Massa O; Rodriguez-Bada P; Colombo C; Lenzi L; Garcia-Gimeno MA; Bermudez-Silva FJ; Rodriguez de Fonseca F; Banin P; Aledo JC; Baixeras E; Sanz P; Cuesta-Muñoz AL
Mol Endocrinol; 2009 Dec; 23(12):1983-9. PubMed ID: 19884385
[TBL] [Abstract][Full Text] [Related]
13. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
14. Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor.
Murphy R; Tura A; Clark PM; Holst JJ; Mari A; Hattersley AT
Diabetologia; 2009 Jan; 52(1):154-9. PubMed ID: 18974968
[TBL] [Abstract][Full Text] [Related]
15. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
Christesen HB; Tribble ND; Molven A; Siddiqui J; Sandal T; Brusgaard K; Ellard S; Njølstad PR; Alm J; Brock Jacobsen B; Hussain K; Gloyn AL
Eur J Endocrinol; 2008 Jul; 159(1):27-34. PubMed ID: 18450771
[TBL] [Abstract][Full Text] [Related]
16. Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation.
Arya VB; Kalitsi J; Hickey A; Flanagan SE; Kapoor RR
Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31096182
[TBL] [Abstract][Full Text] [Related]
17. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Hypoglycemia Due to a Novel Activating Glucokinase Variant in an Adult - a Molecular Approach.
Koneshamoorthy A; Seniveratne-Epa D; Calder G; Sawyer M; Kay TWH; Farrell S; Loudovaris T; Mariana L; McCarthy D; Lyu R; Liu X; Thorn P; Tong J; Chin LK; Zacharin M; Trainer A; Taylor S; MacIsaac RJ; Sachithanandan N; Thomas HE; Krishnamurthy B
Front Endocrinol (Lausanne); 2022; 13():842937. PubMed ID: 35370948
[TBL] [Abstract][Full Text] [Related]
19. Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism.
Vezzosi D; Bennet A; Fauvel J; Boulanger C; Tazi O; Louvet JP; Caron P
Eur J Endocrinol; 2003 Nov; 149(5):413-9. PubMed ID: 14585087
[TBL] [Abstract][Full Text] [Related]
20. HNF4A mutation: switch from hyperinsulinaemic hypoglycaemia to maturity-onset diabetes of the young, and incretin response.
Arya VB; Rahman S; Senniappan S; Flanagan SE; Ellard S; Hussain K
Diabet Med; 2014 Mar; 31(3):e11-5. PubMed ID: 24299156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
